NeoMedia Technologies, Inc (NEOM): Phoenix, it does seem that they have don...

Phoenix, it does seem that they have done

inforit1 · 2006-04-09T17:02:49.8570000Z

Phoenix, it does seem that they have done alot, but where are our results? I am failing to see them.

Play Episode

7min

Proactive - Interviews for investors

Directa Plus CEO on Q1 revenue jump on new contracts in Romania and textile market recovery

Directa Plus CEO Giulio Cesareo talked with Proactive's Stephen Gunnion about the company’s strong start to 2025 and the strategic impact of its environmental operations. Cesareo shared that the company saw a 40% rise in first-quarter revenue to approximately €2 million, driven by new contracts in Romania and a recovering textile market in Italy. “We have a significant contract with Midia International,” Cesareo explained, adding that work on oil recovery from drilling platforms resumed after a slowdown in 2024 due to the war in the Black Sea. The full acquisition of Setcar, a Romanian environmental service company, plays a central role in the company’s strategy. Cesareo highlighted that Setcar not only holds a full suite of environmental certifications but also occupies a “geopolitical significant position” as a potential gateway to Ukraine’s reconstruction. Environmental applications remain a key focus for Directa Plus, especially the use of its graphene materials to decontaminate water and soil. In collaboration with OMV Petrom, the company successfully decontaminated 44,000 cubic meters of water, recovering 10,000 barrels of crude oil. Research and development are also advancing. Directa Plus is working with Nant G Power on battery materials and refocusing on opportunities in sectors like tyres and PFAS filtration. Cesareo stated, “There are significant opportunities, despite the actual crisis, that can be captured by our innovative material.” With €4 million in cash and a burn rate that extends funding through to August 2026, Cesareo believes the company is well-positioned for the year ahead. For more exclusive interviews and updates, visit Proactive's YouTube channel. Don’t forget to like this video, subscribe, and enable notifications to stay up to date. #DirectaPlus #GrapheneTechnology #EnvironmentalSolutions #Setcar #OilRecovery #PFAS #CleanTech #NantGPower #UkraineReconstruction #TextileInnovation #BatteryMaterials #Q12025 #InvestingInGraphene #Proa

Proactive - Interviews for investors

Ananda Pharma adds former GW Pharmaceuticals executive as strategic advisor, advances MRX1

Ananda Pharma Plc finance director Jeremy Sturgess-Smith talked with Proactive's Stephen Gunnion about the appointment of Chris Tovey as a strategic advisor. Tovey brings significant experience from his time as chief operating officer at GW Pharmaceuticals and later Jazz Pharmaceuticals. According to Sturgess-Smith: “He’s going to bring all that experience to Ananda,” helping guide the company through its regulatory path and corporate development. Sturgess-Smith also touched on Ananda securing ethics approval to begin its first human trial of MRX1, a key milestone for the company’s therapeutic pipeline. He noted this was the first ethics approval of its kind for any Ananda trial, with recruitment expected to begin shortly in Australia. “It’s very, very exciting to have that ethics approval in the bag,” he said. Looking ahead, the company also expects ethics approvals for studies into chemotherapy-induced peripheral neuropathy and endometriosis in the next six months. For more interviews and updates, visit Proactive's YouTube channel. Don’t forget to like this video, subscribe, and hit the notification bell to stay informed.** #AnandaPharma #MRX1Trial #ClinicalTrials #CannabinoidMedicine #BiotechNews #PharmaceuticalInnovation #EthicsApproval #GWPharma #DrugDevelopment #Epidiolex #HealthInnovation #ProactiveInvestors

Proactive - Interviews for investors

Alkane hits high-grade gold at Tomingley

Alkane Resources Ltd managing director Nic Earner talked with Proactive about recent high-grade gold intercepts and ongoing resource expansion at the Tomingley gold operations in New South Wales. Earner detailed strong results from underground drilling at both the Caloma and Roswell zones, with intercepts showing multiple grams per tonne over substantial widths. “We’ve had some very, very high-grade hits… tens of metres at plus ten grams in Roswell,” he noted, highlighting the significant contribution these results will make to near-term reserve updates and future production planning. The company is confident these results will support mine life extensions well into the 2030s. Reserve and resource updates, including for Caloma One and Caloma Two, are expected in the August–September period, following analysis of the June 30 data. Earner also touched on Alkane’s recent financial performance, stating: “It’s been a great quarter… we had a great cash build,” helped by strong production and a high Australian-dollar gold price. He confirmed guidance remains on track, with 17,500 ounces produced and expectations of reaching 19,000 ounces by quarter end. Alkane continues to advance permitting for the highway relocation and is actively progressing exploration across both the Boda-Kaiser project and Tomingley region. The company is also evaluating organic growth and potential collaboration opportunities. Visit Proactive’s YouTube channel for more investor interviews. Don’t forget to like this video, subscribe, and turn on notifications for future updates. #AlkaneResources #GoldMining #Tomingley #GoldExploration #MiningNews #ASX #OTCMarkets #GoldDrilling #ResourceUpdate #CashFlow #GoldInvesting #RoswellDrilling

Proactive - Interviews for investors

Tonix Pharmaceuticals launches :TONIX ONE™ A digital breakthrough in migraine management

Tonix Pharmaceuticals is making waves in the healthcare industry with the launch of TONIX ONE™ a fully integrated digital platform designed to empower migraine patients with better tools for understanding and managing their condition. In an exclusive discussion with Proactive’s Steve Darling, Dr. Seth Lederman, CEO of Tonix Pharmaceuticals, unveiled the platform’s innovative features and strategic partnerships aimed at transforming migraine care. By collaborating with UpScript Telemedicine, ProModRx, Blink Health, and a leading mobile application specializing in disease tracking, symptom reporting, and management, TONIX ONE offers a comprehensive, patient-centric solution. Dr. Lederman highlighted that TONIX ONE™ beyond conventional migraine education by providing critical insights into the limitations of oral medications, which can sometimes result in delayed or ineffective symptom relief. The platform bridges the gap between patients and healthcare providers, offering direct access to migraine specialists via telehealth consultations and seamless e-prescription requests—ensuring a faster, more effective pathway to treatment. With this initiative, Tonix Pharmaceuticals aims to not only educate and empower patients in their treatment journey but also eliminate the barriers to care that many migraine sufferers face. By integrating advanced digital health solutions,TONIX ONE™ stands at the forefront of a new era in migraine management, offering patients greater control over their health and well-being. #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp #Biotech #MigraineTreatment #TonixOne #DigitalHealth #Telemedicine #ZembraceSymTouch #Tosymra #HealthcareInnovation #PharmaNews #ProactiveInvestors

Followers	0
Posts	658
Boards Moderated	0
Alias Born	01/11/2006

Volume:	-
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

NEOM Detailed Quote

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Go Ad-Free